[go: up one dir, main page]

CS621585A2 - Method of analynprolinone derivatives production - Google Patents

Method of analynprolinone derivatives production Download PDF

Info

Publication number
CS621585A2
CS621585A2 CS856215A CS621585A CS621585A2 CS 621585 A2 CS621585 A2 CS 621585A2 CS 856215 A CS856215 A CS 856215A CS 621585 A CS621585 A CS 621585A CS 621585 A2 CS621585 A2 CS 621585A2
Authority
CS
Czechoslovakia
Prior art keywords
formula
compound
group
alkyl
carboxy
Prior art date
Application number
CS856215A
Other languages
Czech (cs)
English (en)
Inventor
Geoffrey Allan
Donald Bull
George W Hardy
Grahame R Lee
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CS621585A2 publication Critical patent/CS621585A2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS856215A 1984-09-01 1985-08-30 Method of analynprolinone derivatives production CS621585A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848422165A GB8422165D0 (en) 1984-09-01 1984-09-01 Compounds

Publications (1)

Publication Number Publication Date
CS621585A2 true CS621585A2 (en) 1989-08-14

Family

ID=10566163

Family Applications (1)

Application Number Title Priority Date Filing Date
CS856215A CS621585A2 (en) 1984-09-01 1985-08-30 Method of analynprolinone derivatives production

Country Status (16)

Country Link
EP (1) EP0174162A3 (fr)
JP (1) JPS6183198A (fr)
KR (1) KR860002501A (fr)
AU (1) AU581455B2 (fr)
CS (1) CS621585A2 (fr)
DD (1) DD236522A5 (fr)
DK (1) DK396885A (fr)
ES (6) ES8703418A1 (fr)
FI (1) FI853336L (fr)
GB (1) GB8422165D0 (fr)
GR (1) GR852113B (fr)
HU (1) HUT39190A (fr)
MC (1) MC1695A1 (fr)
PL (3) PL265523A1 (fr)
PT (1) PT81055B (fr)
ZA (1) ZA856672B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT46045A (en) * 1986-02-28 1988-09-28 Wellcome Found Process for producing new compounds and pharmaceutics comprising same
EP0237239A3 (fr) * 1986-02-28 1988-08-17 The Wellcome Foundation Limited Composés
US5036051A (en) * 1987-10-06 1991-07-30 Abbott Laboratories Glaucoma treatment
US4927807A (en) * 1987-10-06 1990-05-22 Abbott Laboratories Glaucoma treatment
US5346887A (en) * 1987-10-06 1994-09-13 Abbott Laboratories Glaucoma treatment
US5187183A (en) * 1988-06-15 1993-02-16 Brigham & Women's Hospital S-nitroso derivatives of ACE inhibitors and the use thereof
US5025001A (en) * 1988-06-15 1991-06-18 Brigham And Women's Hospital S-nitroso derivatives of ACE inhibitors and the use thereof
US5356890A (en) * 1988-06-15 1994-10-18 Brigham And Women's Hospital S-nitroso derivatives of ace inhibitors and the use thereof
US5059589A (en) * 1988-09-08 1991-10-22 Abbott Laboratories Glaucoma treatment
US4916129A (en) * 1989-01-19 1990-04-10 E. I. Du Pont De Nemours And Company Combination β-blocking/angiotensin II blocking antihypertensives
US9259535B2 (en) 2006-06-22 2016-02-16 Excelsior Medical Corporation Antiseptic cap equipped syringe
US11229746B2 (en) 2006-06-22 2022-01-25 Excelsior Medical Corporation Antiseptic cap
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
US10166381B2 (en) 2011-05-23 2019-01-01 Excelsior Medical Corporation Antiseptic cap
EP2731658B1 (fr) 2011-07-12 2020-04-01 Pursuit Vascular, Inc. Dispositif de distribution d'agent antimicrobien dans cathéter transdermique
WO2015168677A1 (fr) 2014-05-02 2015-11-05 Excelsior Medical Corporation Emballage de bande pour bouchon antiseptique
AU2016262400B2 (en) 2015-05-08 2021-01-21 Icu Medical, Inc. Medical connectors configured to receive emitters of therapeutic agents
EP4194043A1 (fr) 2016-10-14 2023-06-14 ICU Medical, Inc. Capuchons désinfectants pour raccords médicaux
WO2018204206A2 (fr) 2017-05-01 2018-11-08 Icu Medical, Inc. Raccords de fluide médical et procédés pour fournir des additifs dans des conduites de fluide médical
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
WO2020106985A1 (fr) 2018-11-21 2020-05-28 Pursuit Vascular, Inc. Dispositif antimicrobien comprenant un capuchon avec bague et insert
JP2024500319A (ja) 2020-12-07 2024-01-09 アイシーユー・メディカル・インコーポレーテッド 腹膜透析キャップ、システム、及び方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3705907A (en) * 1970-02-19 1972-12-12 Sandoz Ltd 4-(2-hydroxy)-3-aminopropoxy)-indole derivatives
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
DE3177130D1 (de) * 1980-08-30 1990-01-11 Hoechst Ag Aminosaeurederivate, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung.
GR75019B (fr) * 1980-09-17 1984-07-12 Univ Miami
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4462943A (en) * 1980-11-24 1984-07-31 E. R. Squibb & Sons, Inc. Carboxyalkyl amino acid derivatives of various substituted prolines
EP0080822A1 (fr) * 1981-11-27 1983-06-08 Beecham Group Plc Peptides issus de prolinol, à activité anti-hypertensive
IE55867B1 (en) * 1981-12-29 1991-02-14 Hoechst Ag New derivatives of bicyclic aminoacids,processes for their preparation,agents containing these compounds and their use,and new bicyclic aminoacids as intermediates and processes for their preparation
DE3360065D1 (en) * 1982-03-08 1985-03-28 Schering Corp Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
EP0099709A3 (fr) * 1982-07-19 1985-11-13 Imperial Chemical Industries Plc Dérivés d'amide

Also Published As

Publication number Publication date
ES8801672A1 (es) 1988-02-16
PL265523A1 (en) 1988-02-04
ES553610A0 (es) 1988-01-01
ES553614A0 (es) 1988-02-16
EP0174162A2 (fr) 1986-03-12
ES8801313A1 (es) 1988-01-01
EP0174162A3 (fr) 1988-07-27
KR860002501A (ko) 1986-04-26
ZA856672B (en) 1987-05-27
ES8801312A1 (es) 1987-12-16
PT81055A (en) 1985-09-01
AU4693285A (en) 1986-03-06
ES553613A0 (es) 1988-01-01
HUT39190A (en) 1986-08-28
PL265522A1 (en) 1988-05-12
FI853336L (fi) 1986-03-02
ES8703418A1 (es) 1987-02-16
AU581455B2 (en) 1989-02-23
ES8801310A1 (es) 1988-01-01
PT81055B (en) 1987-07-02
ES546595A0 (es) 1987-02-16
DD236522A5 (de) 1986-06-11
ES553612A0 (es) 1987-12-16
PL255192A1 (en) 1987-09-21
GB8422165D0 (en) 1984-10-03
JPS6183198A (ja) 1986-04-26
DK396885D0 (da) 1985-08-30
GR852113B (fr) 1985-12-24
FI853336A0 (fi) 1985-08-30
DK396885A (da) 1986-03-02
ES8801311A1 (es) 1987-12-16
MC1695A1 (fr) 1986-07-18
ES553611A0 (es) 1987-12-16

Similar Documents

Publication Publication Date Title
CS621585A2 (en) Method of analynprolinone derivatives production
US5071837A (en) Novel renin inhibiting peptides
AU625456B2 (en) Diol-containing renin inhibitors
KR850000847B1 (ko) 아미노산 유도체의 제조방법
US4668797A (en) Bicyclic aminoacids as intermediates and processes for their preparation
WO1989007610A1 (fr) INHIBITEUR DE RENINE CONTENANT DES AMINOACIDES AVEC UN HETEROATOME alpha
SK64993A3 (en) Hydroxamic acid derivatives, method of their preparation and medicaments with their content
HU193288B (en) Process for production of substituated derivatives of lactane
EP0315815A1 (fr) Inhibiteurs de la rénine ayant une chaîne branchée
PL178326B1 (pl) Inhibitory metaloproteazy substancji międzykomórkowej oraz kompozycja farmaceutyczna
FI113965B (fi) 8-okso-4-oksa-1,7-diatsatrisyklo-oktadekatetraen-9-yylikarbamoyylijohdannaiset matriisimetalloproteaasi-inhibiittoreina
JPH09501430A (ja) マトリックスメタロプロテアーゼ阻害因子
JPH07500604A (ja) 高血圧治療用エチルアラニンアミノジオール化合物
JPH0559105B2 (fr)
US4556655A (en) Antihypertensive compounds having both diuretic and angiotensin converting enzyme inhibitory activity
EP0399556B1 (fr) Hétérocycles amino-substitués comme inhibiteurs de la rénine
US4490386A (en) Phosphate salts of 1-[2-[(1-alkoxycarbonyl-3-aralkyl)-amino]-1-oxoalkyl]octahydro-1H-indole-2-carboxylic acids, preparation of, and medical compositions thereof
US20020061840A1 (en) Tripeptide compounds useful as selective inhibitors of aminopeptidase A and corresponding pharmaceutical compositions
JPH09118662A (ja) 尿素誘導体
US5151432A (en) Substituted amino acid compounds
EP0203450B1 (fr) Dérivés d'amino-acides bicycliques, leur procédé de préparation, les agents les contenant et leur emploi
EP0192393A2 (fr) Dérivés d'alkyl-furanone
EP0432975A1 (fr) Inhibiteurs cycliques de la rénine
IE62354B1 (en) Fused azepinone and azocinone derivatives, processes for their preparation, agents containing them and their use, and intermediates in their preparation
JPH0379339B2 (fr)